Articles in: Drug & Medical Device Watch

Home » Archive » Drug & Medical Device Watch

IVC Filters fail to improve Anticoagulant Therapy

IVCfilter600x4801

A study published in Medscape April 2015 suggests retrievable inferior vena cava (IVC) filters fail to further improve outcomes in patients with severe acute pulmonary embolism, if those patients already receive anticoagulation therapy. The combination of a retrievable IVC filter plus anticoagulation failed to reduce the risk for symptomatic recurrent pulmonary embolism at three months, in comparison with anticoagulation alone.
IVC …

FacebookTwitterGoogle+Share

Essure Safety examined by FDA

essure_birth_control_lawsuit

Amid reports of deaths linked to Essure, a permanent birth control device, an FDA panel has decided to investigate. Law360 reported on June 25, 2015 that an FDA panel will review the safety of Bayer HealthCare AG’s permanent birth control insert Essure.
The agency has received health problem reports not warned of on the product’s label. FDA said at least four …

FacebookTwitterGoogle+Share

Pelvic Mesh Trial set for Dallas Sept. 2015

Justice Peaking Blog

A trial date for the next pelvic mesh trial is set for September 21, 2015 in Dallas. The 95th Judicial District Court will hear the case with Judge Ken Molberg presiding. The plaintiff alleges that she was injured by a defective Ethicon Prosima mesh which was placed in her to treat pelvic organ prolapse. Ethicon recalled the Prosima sling from …

FacebookTwitterGoogle+Share

Nexium Heart Attack Risks

nexium

Nexium, Prilosec and Prevacid – heartburn drugs – have been linked to  increased heart attack risks. These proton pump inhibitor drugs (PPIs) are up to 21% more likely to give their users a   heart attack than people who do not use the antacids, according to researchers from Houston (Texas) Methodist  and California’s Stanford University. A recent  NPR radio report detailed …

FacebookTwitterGoogle+Share

Onglyza Diabetes Drug linked to Heart Failure

onglyza2

An FDA review published April 14, 2015 links the diabetes drug Onglyza to an increased risk of heart failure. Onglyza may also increase the risk of pancreatic cancer.
Onglyza (saxagliptin) – co-developed by Bristol Meyers Squibb and AstraZeneca – joins a list of some newer diabetes drugs that have alarmed patients and their doctors. Several lawsuits have  been filed regarding complications …

FacebookTwitterGoogle+Share

Zofran Birth Defect Lawsuit filed in Arkansas

Zofran

The mother of a baby born with a cleft lip after she took  Zofran in her first trimester filed a lawsuit against GlaxoSmithKline (GSK) on May 21, 2015. The suit charges the company failed to warn of the drug’s birth defect risks.
The Arkansas mother, Jill Cox, filed her case in the the U.S. District Court for the Eastern District of …

FacebookTwitterGoogle+Share

Depakote Lawsuit brings $38 Million Verdict

Depakote-Copy-300x206

On May 27, 2015, a jury in St. Louis, Missouri awarded $38 million to a Minnesota girl injured by Depakote. The jury added $23 million in punitive damages to the $15 million they had earlier awarded the now 12-year-old girl. The jury agreed with plaintiff’s attorneys’ charges that Depakote, an epilepsy drug made by Abbott Laboratories, caused the girl’s birth …

FacebookTwitterGoogle+Share

FBI examines Hysterectomy Device Cancer Link

Logo Box 2012

The Wall Street Journal reported on May 27, 2015 that the FBI is investigating whether Johnson & Johnson, the largest maker of a morcellator surgical tool found to spread uterine cancer, knew about the hazards.
People who have been interviewed by the FBI regarding the morcellator said the agency is investigating what Johnson & Johnson knew about the morcellator’s hazards before …

FacebookTwitterGoogle+Share

Morcellators for Hysterectomy linked with Cancer

Logo Box 2012

Johnson & Johnson company Ethicon, Inc. halted sales last year of its power morcellators after federal health regulators issued morcellator warnings. The FDA no longer considers morcellators – used to remove fibroids or other noncancerous growths during a hysterectomy or a myomectomy – to be safe and effective.
Morcellators Recalled
Johnson & Johnson voluntarily recalled three of its power morcellators last year …

FacebookTwitterGoogle+Share

$100 Million Mesh Verdict for Delaware Woman

Justice Peaking Blog

May 28, 2015 – A Delaware jury ordered Boston Scientific to pay a woman $100 million in damages today for injuries she suffered from having been implanted with plastic transvaginal mesh.
It was a record amount, surpassing the previous high of $73 million awarded to a Texas woman last Sept. in Dallas. The Delaware jury awarded Deborah Barba $25 million in …

FacebookTwitterGoogle+Share

Next Pelvic Mesh Trial for Matthews & Associates

johnson-johnson-pharmaceutical-research-development-logo

The country’s next pelvic mesh trial in the country will be tried by Matthews & Associates Law Firm of Houston. It will be the fourth such trial handled by the firm, which has won jury verdicts for plaintiffs in each of its three prior transvaginal mesh trials, along with lawyers from Freese & Goss.
Ramirez vs. Johnson & Johnson
Ramirez vs. Johnson …

FacebookTwitterGoogle+Share

Actos Settlement $2.4 Billion

actos-tablets-30mg1

An Actos settlement of $2.4 billion to pay some 9,000 cases brought by U.S. citizens who allege Actos’ maker Takeda concealed the drug’s cancer risks. Actos is a diabetes medicine sold by the Osaka, Japan company. Takeda lost five lawsuits in which plaintiffs charged that Actos raised the risk of bladder cancer, including one case in which a jury …

FacebookTwitterGoogle+Share

Benicar Lawsuits centralized in New Jersey

benicar_c

A panel of federal judges has centralized 15 Benicar Lawsuits against Daiichi Sankyo and Forest Laboratories in New Jersey federal court. Plaintiffs in these cases allege Benicar caused them severe gastrointestinal injuries which include chronic diarrhea, malnutrition, dehydration and sprue-like enteropathy.
Benicar Lawsuit Evaluation
If you or a loved one has been injured by the side effects of Benicar (olmesartan), contact our …

FacebookTwitterGoogle+Share

Johnson & Johnson alleges Fraud in Massive Pelvic Mesh Filings

johnson-and-johnson-squarelogo

Johnson & Johnson and Ethicon  filed a motion in the pelvic mesh MDL in West Virginia alleging, among other things, that there is a direct relationship between the number of filings in the MDL and the inappropriate direct solicitation of women by unscrupulous groups and individuals. Based on these alleged solicitations, Ethicon suggested to the Court that many of the …

FacebookTwitterGoogle+Share

Teva’s Generic Profits rival Drug Brands

Teva

Supreme Court Rules Generic Drugs are not Equivalent
With help from five corporate champions that sit on the U.S. Supreme Court, generic drug giant Teva has cracked the world’s top ten drug makers in profits. The world’s largest generic drug maker, however, falls far shy of the top ten list for drug companies that are treated like most adults, those that …

FacebookTwitterGoogle+Share

CT Scans deliver Dangerous Radiation

ct-scan

Because heavy doses of ionizing radiation are known to cause leukemia and other cancers, a new study shows that CT scans may not be the best diagnostic tool for doctors. The federally funded, $40 million study shows that people who receive a heart CT scan to investigate chest pain have no less risk of dying or being hospitalized months afterwards …

FacebookTwitterGoogle+Share

Johnson & Johnson sells Contaminated Children’s Tylenol

johnson-and-johnson-squarelogo

A Johnson & Johnson unit plead guilty March 10, 2015 to selling children’s medications contaminated with metal particles and other toxic substances including nickel, iron and chromium. J&J and McNeil-PPC Inc. agreed to pay $20 million in criminal fines in addition to the guilty plea for selling contaminated children’s versions of over-the-counter medications including Tylenol and Motrin.
J&J consistently fails its …

FacebookTwitterGoogle+Share

Johnson & Johnson hit with $5.7 Million Pelvic Mesh Verdict

johnson-and-johnson-squarelogo

Johnson & Johnson and Ethicon lost a $5.7 million jury verdict in Bakersfield, Calif. today, March 5, 2015. A jury of 12 awarded plaintiff Coleen Perry $700,000 in actual damages and $5 million in punitives after three days of  deliberation following a two-month trial. It was the fourth pelvic mesh jury trial which ended in jurors awarding more than $1 …

FacebookTwitterGoogle+Share

Zofran Birth Defect Risks

zofran-250x250

The anti-nausea drug Zofran increases birth defect risks, including heart defects, cleft lip and cleft palate. The FDA has not approved Zofran use for pregnant women. No long-term studies have proven Zofran (generic, Oldansetron) is safe for pregnant mothers. Nevertheless, some doctors continue to prescribe Zofran off-label for severe morning sickness.
Zofran Birth Defect Risks
Though at least one study of Zofran …

FacebookTwitterGoogle+Share

Dr. Margolis testifies against Johnson & Johnson

Tom Margolis

Dr. Tom Margolis testified against Johnson & Johnson for the plaintiff, Coleen Perry, on Feb. 10, 2015 in Bakersfield, Calif. in her ongoing trial against the Big Pharma giant and Ethicon.
Through questioning, Dr. Margolis testified that he has performed more than 15,000 female pelvic floor surgeries, some 5,500 for stress urinary incontinence. The plaintiff, Mrs. Perry, had an Ethicon sling …

FacebookTwitterGoogle+Share

Plaintiff testifies in Pelvic Mesh Trial against Johnson & Johnson

Ethicon_Transvaginal_Mesh

Defense lawyers for Johnson & Johnson put the con in Ethicon last week. They claimed during opening statement in Perry vs. Ethicon (see the petition) that plaintiff Coleen Perry had contacted lawyers before undergoing additional surgery to have her pelvic mesh sling removed. The cynical implication was clear: she had the sling removed in order to sue the company. But …

FacebookTwitterGoogle+Share

Johnson & Johnson faces Mesh Trial in California

Ethicon_Transvaginal_Mesh

Johnson & Johnson faces another pelvic mesh trial in California this week, in Superior Court in Kern County. (See Perry v. Ethicon Petition) The bellwether jury trial in product liability suit alleges that pelvic mesh manufactured by Johnson & Johnson’s Ethicon unit was defectively designed and caused injuries after being implanted in plaintiff Colleen Perry. This is the first case …

FacebookTwitterGoogle+Share

Transvaginal Mesh Trial for Woman killed by Infection

prolift_mesh_implant_anterior_111405

Jane Akre of Mesh Medical Device News Desk reports from Missouri that Dr. Anne Weber testified this week on day four of the trial of Budke v. Ethicon (Johnson & Johnson). Family survivors of Joan Budke claim Johnson & Johnson’s Prolift pelvic mesh implant led to her death 16 months after the experimental plastic contraption was sewn inside her. Ms. …

FacebookTwitterGoogle+Share

Judge urges Mesh Maker to settle Cases

transvaginal-mesh-closer-look

It’s not often that a federal judge urges a defendant to settle cases. But a judge with tens of thousands of cases in his court, a judge with the largest MDL in the history of MDL courts, might be granted some leeway for taking unprecedented action. According to Bloomberg.com, at a Dec. 9 hearing in Charleston, W. Va., U.S. district …

FacebookTwitterGoogle+Share

Xarelto Maker, Marketer fight MDL

Bayer

Xarelto Maker and Marketer, Bayer AG and Johnson & Johnson, are both resisting the creation of a multi district litigation court (MDL) to handle Xarelto cases. Bloomberg reported last week that Bayer AG and Johnson & Johnson, the companies that make and market Xarelto, respectively, do not want to centralize 50 lawsuits into one federal court under one judge. The …

FacebookTwitterGoogle+Share

Boston Scientific loses $18.5 Million Federal Verdict

Boston Scientific

Boston Scientific Corp. (BSX) just lost a transvaginal mesh trial for the second time in two weeks.  In a West Va. federal courtroom on Nov. 20, jurors found the company had sold defective vaginal mesh implants to four women who had brought suit against the company.
Jurors deliberated for more than six hours, then awarded $18.5 million in total damages to …

FacebookTwitterGoogle+Share

$27 Million Verdict against Boston Scientific

Boston Scientific

MIAMI — A federal jury in Florida on Nov. 13, 2014 hit Boston Scientific Corp. with a $26.7 million verdict in a trial that featured four women as plaintiffs. All four testified that they were injured by a defective pelvic mesh implant. The nine-person jury in the defective product trial of the women’s pelvic mesh product made by Boston Scientific …

FacebookTwitterGoogle+Share

Bankruptcy & your Lawsuit

Lizy Santiago

Many people who have filed a drug injury lawsuit against a pharmaceutical company are also dealing with financial woes. A person with a drug injury case has often sustained substantial medical costs as well as work loss, all of which can lead to near-catastrophic financial difficulties. Many people who find themselves in such a position have consider or will consider …

FacebookTwitterGoogle+Share

Transvaginal Mesh Catastrophe

transvaginal-mesh-closer-look

Like many things in this life, the idea of mesh sounds sensible, but the application and reality are not. The idea of mesh is that it is easier to install than it is to simply suture, as was done for 50 years, before a man had a notion to place plastic in women’s vaginas. And because mesh is easier to …

FacebookTwitterGoogle+Share

Verdicts Mount to $100 Million against Transvaginal Mesh Makers

Logo Box 2012

Nearly $100 Million in Damages in Six Trials
As six more transvaginal mesh trials are scheduled for the next year around the country, mesh makers can take little solace from the outcomes of six trials won by plaintiffs so far.  Those six alone have rendered nearly $100 million in damage awards for women implanted with the plastic products the manufacturers claim …

FacebookTwitterGoogle+Share

Xarelto Dangers rival Pradaxa

Xarelto_Bottle_LR

Xarelto dangers rival those of Pradaxa, according to an Institute of Safe Medication Practices (ISMP) Report (PDF). Xarelto has even surpassed rival blood thinner Pradaxa for prescriptions written and for its number of severe adverse events reported by users.
ISMP Analysis
After reviewing and analyzing the FDA’s adverse event data, the ISMP states that the number of complaints submitted involving Xarelto surpassed …

FacebookTwitterGoogle+Share

MDL in Chicago for Low-T Lawsuits

androgel-picture

A Multi District Litigation court is set up when the judiciary is made to believe there will be a great number of related cases in a given litigation. An MDL court can be set up to handle one sole manufacturer – such as cases involving AbbVie Pharmaceuticals, the maker of Androgel – or to handle cases against several manufacturers, such …

FacebookTwitterGoogle+Share

Julie Rhoades beats Johnson & Johnson in TVM Skirmish

Julie Rhoades092

DENVER — Matthews & Associates attorney Julie Rhoades battled Johnson & Johnson lawyers at the Tenth Circuit Court of Appeals on April 11 and prevailed.
Johnson & Johnson attorneys attempted to remove 650 transvaginal mesh cases from Oklahoma State Court into the federal multi-district litigation court (MDL) set up in West Virginia, where Judge Joseph Goodwin has, thus far, not been …

FacebookTwitterGoogle+Share

J & J loses $1.2 million Verdict in Transvaginal Mesh Case

Justice Blind

DALLAS – On Thursday, April 3, a 12-person jury in Dallas ordered Johnson & Johnson to pay a Texas woman $1.2 million for a defective plastic sling – the TVT-O – which J & J’s Ethicon division makes and markets for stress urinary incontinence. Several law firms, including Matthews & Associates and Freese & Goss, represented the woman, Ms. Linda …

FacebookTwitterGoogle+Share

Batiste vs. Johnson & Johnson Day 6

Tom Margolis

On Tuesday, March 25, Dr. Tom Margolis testified for the plaintiff, Ms. Batiste, in the sixth day of the trial of Batiste vs. Johnson & Johnson. Ms. Batiste continues to experience pain and dyspareunia which she attributes to her Ethicon sling.  Her case is being heard in the 95th Judicial District Court of Judge Ken Molberg, George L. Allen, Sr. …

FacebookTwitterGoogle+Share

JAMA attacked by Testosterone Money

androgel-picture

Like mountain goats locking horns to determine supremacy, testosterone battles are raging between researchers not beholden to Big Pharma and researchers who are.
The Wall Street Journal reported yesterday that researchers paid by companies promoting testosterone therapy have come out in full-throated attack against a study published in Nov. 2013 in the Journal of the American Medical Association (JAMA). The study …

FacebookTwitterGoogle+Share

Attorney General asked to investigate J & J

johnson-johnson-pharmaceutical-research-development-logo

Johnson & Johnson destroyed perhaps hundreds of thousands of pages of documents as well as computer hard drives after the company was notified that it needed to preserve them for ongoing TransVaginal Mesh Litigation.
A consumer group, Corporate Action Network (CAN) has now responded to the company’s illegal destruction by asking the Department of Justice (DOJ) to launch an investigation into …

FacebookTwitterGoogle+Share

Ethicon TransVaginal Mesh Trial in Dallas – Day 2

d8-peggy-pence-200

Wednesday, March 19 marked the second day of an Ethicon TransVaginal Mesh Trial in Dallas. A 64-year-old Texas woman’s lawsuit was  brought against Johnson & Johnson’s Ethicon division. The woman underwent two revision surgeries after being implanted in 2011 with a transvaginal mesh sling – the TVT-O – made by Ethicon. She continues to experience pain and dyspareunia (pain during …

FacebookTwitterGoogle+Share

Transvaginal Mesh Trial Opens in Dallas

Justice Blind

DALLAS, TEXAS — Within view of the infamous Dealey Plaza – where gunmen ambushed President John F. Kennedy 50 years ago – in a courtroom on the 6th floor of what locals call the “New Tower,” a Texas woman who claims she was injured by plastic mesh sewn into pelvic muscles in her vagina had her first day in court …

FacebookTwitterGoogle+Share

Transvaginal Mesh Trial in Dallas this week

johnson-johnson-pharmaceutical-research-development-logo

A Transvaginal Mesh Trial in Dallas this week will be prosecuted by Texas attorneys from Dallas and Houston.
Tomorrow, March 18, jurors will hear opening arguments  in a Transvaginal Mesh Trial in a Dallas courtroom.  The plaintiff, a 61-year-old Texas woman, will be represented by Freese & Goss, with assistance from Matthews & Associates and Dallas attorney Rich Capshaw. This case …

FacebookTwitterGoogle+Share

Free Legal Consultation

Please leave this field empty.